Abstract. The present study investigated an ethanol extract of the aerial part of Aralia cordata Thunb. (Araliaceae) for possible neuroprotective effects on neurotoxicity induced by amyloid β (Aβ) protein (25 -35) in cultured rat cortical neurons and antidementia activity in mice. Exposure of cultured cortical neurons to 10 μM Aβ(25 -35) for 36 h induced neuronal apoptotic death. At 1 -10 μg/ml, A. cordata inhibited neuronal death, elevation of intracellular calcium ([Ca 2+ ] i ), glutamate release into the medium, and generation of reactive oxygen species (ROS) induced by in primary cultures of rat cortical neurons. Memory loss induced by intracerebroventricular injection of ICR mice with 15 nmol Aβ(25-35) was inhibited by chronic treatment with A. cordata (50 and 100 mg/kg, p.o. for 7 days) as measured by a passive avoidance test, and corresponding reductions were observed in brain cholinesterase activity and neuronal death measured histologically in the hippocampal region. Oleanolic acid isolated from A. cordata also inhibited neuronal death, elevation of [Ca 2+ ] i , glutamate release, and generation of ROS induced by Aβ(25-35) in cultured rat cortical neurons, suggesting that the neuroprotective effect of A. cordata may be, at least in part, attributable to this compound. From these results, we suggest that the antidementia effect of A. cordata is due to its neuroprotective effect against Aβ(25-35)-induced neurotoxicity and that A. cordata may have a therapeutic role in preventing the progression of Alzheimer's disease.
Introduction
Alzheimer's disease (AD) is a neurodegenerative disorder characterized clinically by cognitive impairment and pathologically by the appearance of senile plaques and neurofibrillary tangles (1) . Amyloid β protein (Aβ), a 39-to 43-amino-acid peptide fragment derived from amyloid precursor protein, is thought to be closely related to the pathogenesis of AD as the major component of the senile plaques that characterize this disease (2) . Although the precise mechanism of Aβ-induced cell death is not well understood, Aβ neurotoxicity has been speculated to be due to various factors, including oxidative stress, excessive increases in intracellular Ca 2+ ([Ca that were accompanied by a reduction of choline acetyltransferase activity, suggesting that accumulation of Aβ disrupted cholinergic activity and caused the cognitive impairments of AD (7) . Oxidative stresses are also involved in the mechanism of Aβ-induced neurotoxicity and AD pathogenesis (8, 9) . Aβ has been reported to produce hydrogen peroxide and lipid peroxide in neurons and superoxide and proinflammatory cytokines in astrocytes and microglial cells (10, 11) . Antioxidants such as α-tocopherol protect against cytotoxicity induced by Aβ in vitro as well as against learning and memory deficits in vivo (12) . Also, α-tocopherol and anti-inflammatory agents such as indomethacin reportedly slow the progression of AD (13, 14) . Aβ (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) , the core toxic fragment of Aβ , produces similar neurodegenerative properties as Aβ , including oxidative damage, inflammatory responses, and memory impairment (15, 16) . Aralia species belong to the family Araliaceae and have long been recognized in China, Japan, and Korea as therapeutic herbs with antinociceptive, antidiabetic, antioxidant, and anti-inflammatory activities. The root of Aralia cordata Thunb. has been used as a traditional Chinese medicine for rheumatism, lumbago, and lameness (17) . It exhibits pharmacological activities such as analgesia, hypothermia, and prolongation of pentobarbital-induced anesthesia (18) . Diterpenes have been elucidated as analgesic and anti-inflammatory agents of this plant root (18, 19) . In addition to diterpenes, polyacetylenes, a lipid glycerol, and sterols having cyclooxygenase (COX) inhibitory activity have been isolated from the root (20) ; and diterpenes, triterpenes, and a saponin have been isolated as COX-1 and COX-2 inhibitors from the aerial part of this plant (21) . Since reactive oxygen species (ROS) and inflammation are part of the complex series of pathophysiological events that contribute to neurodegenerative diseases such as AD and stroke (22, 23) , free radical scavengers and anti-inflammatory agents have attracted considerable attention as potential neuroprotective agents. We hypothesized that the aerial part of A. cordata might protect neurons against neurodegenerative diseases such as AD and ischemia on the basis of its antioxidant and antiinflammatory activities. The aim of our study was to determine whether A. cordata has a protective effect against Aβ(25-35)-induced memory deficits in mice and Aβ(25-35)-induced neuronal damage in cultured rat cortical neurons. In addition, we identified oleanolic acid as an active component contributing to the neuroprotective effect of A. Cordata against Aβ(25-35)-induced neurotoxicity.
Materials and Methods

Plant material, preparation, and identification
The aerial parts of A. cordata were collected in Daejeon, Korea and identified by one of the authors (Dr. KiHwan Bae). A voucher specimen (CNU 1499) has been deposited in the herbarium at the College of Pharmacy, Chungnam National University, Daejeon, Korea. The dried aerial parts of A. cordata (4 kg) were extracted 3 times with ethanol at room temperature for 3 days, filtered, and concentrated to yield an ethanol extract (300 g, yield: 7.5%), which was then stored at −20°C until required. A. cordata was standardized based on its oleanolic acid contents. Oleanolic acid was determined using reverse-phase high-performance liquid chromatography (HPLC; Shimadzu, Kyoto) equipped with a UV detector. Separation was carried out using a YMC-pack pro C 18 column (5 μm, 10 × 250 mm; Shisheido, Tokyo) at 30°C with a linear gradient of acetonitrile:water (20:80, v/v) and acetonitrile:water (30:70, v/v) as the mobile phase at a flow rate of 1.5 ml/min. The detector wavelength was set at 210 nm. Oleanolic acid was found in the aerial parts of A. cordata at a mean level of 2.20 ± 0.08% (n = 3, Fig. 1 ).
The ethanol extract of A. cordata was suspended in H 2 O (2 L) and then partitioned successively with hexane (2 L × 3), ethyl acetate (2 L × 3), and butanol (2 L × 3) for activity-guided purification. Since the hexanesoluble fraction exhibited considerable activity, this fraction was investigated extensively. The hexanesoluble fraction (85 g) was chromatographed on a silica gel column (30 × 10.0 cm) and eluted with a gradient of hexane-acetone (100:1→1:2) to produce 4 fractions. Repeated silica gel column chromatography (30 × 5.0 cm) of fraction 4 using hexane-acetone (4:1) gave compound 1 (25 mg). 
Experimental animals
Pregnant Sprague-Dawley rats for primary neuronal culture and male ICR mice for the passive avoidance test were supplied by Daehan BioLink Co., Ltd. (Chungbuk, Korea) and housed in an environmentally controlled room at 22 ± 2°C, with a relative humidity of 55 ± 5%, a 12-h light /dark cycle, and food and water ad libitum. The procedures involving experimental animals complied with the animal care guidelines of the National Institutes of Health and the animal ethics committee of Chungbuk National University.
Induction of neurotoxicity in primary cultures of rat cerebral cortical neurons
Primary cortical neuron cultures were prepared using embryonic day 15 -16 Sprague-Dawley rat fetuses, as described previously (24, 25) . Neurotoxicity experiments were performed on neurons after 3 -4 days in culture. Cultured neurons were treated with 10 μM Aβ(25-35) (Bachem, Bubendorf, Switzerland) in serum-free DMEM (Sigma, St. Louis, MO, USA) at 37°C for 36 h (unless otherwise indicated) to produce neurotoxicity. An Aβ(25-35) stock solution of 2 mM was prepared in sterile distilled water, stored at −20°C, and incubated for more than 2 days at 37°C to aggregate before use. A. cordata and oleanolic acid were dissolved in DMSO at concentrations of 10 mg/ ml and 10 mM, respectively, and further diluted in experimental buffers. The final concentration of DMSO was ≤0.1%, which did not affect cell viability. For each experiment, A. cordata, oleanolic acid, N G -nitro-L-arginine methyl ester (L-NAME; Sigma), (5R,10S)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801; RBI, Natick, MA, USA), and verapamil (Sigma) were applied 15 min prior to treatment with 10 μM Aβ (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) . They were also present in the medium during Aβ (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) incubation.
Measurements of Aβ(25-35)-induced neuronal death and intracellular biochemical changes
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT, Sigma) assay and Hoechst 33342 (Molecular Probes, Eugene, OR, USA) staining were performed to measure neuronal death 36-h after exposure of cultured neurons to 10 μM Aβ(25-35), as previously described (24, 25) . Changes in [Ca 2+ ] i were measured with Fluo-4 AM (Molecular Probes), a calcium-sensitive fluorescent dye, using a laser scanning confocal microscope (TCS SP2 AOBS; Leica, Heidelberg GmbH, Germany) with a 488-nm excitation argon laser and 515-nm long-pass emission filters (24, 25) . To measure glutamate secreted into the medium, cells were treated with 10 μM Aβ(25-35) in a HEPES buffer containing 8.6 mM HEPES, 154 mM NaCl, 5.6 mM KCl, 2.3 mM CaCl 2 , and 10 mM glucose at pH 7.4; and glutamate secreted over 24 h was quantified by HPLC with an electrochemical detector (MF series; BAS, Westlafayette, IN, USA) (24) . The microfluorescence of 2',7'-dichlorofluorescein, the fluorescent product of 2',7'-dichlorodihydrofluorescein diacetate (H 2 DCF-DA, Molecular Probes), and a laser scanning confocal microscope (TCS SP2 AOBS, Leica) with 488-nm excitation and 510-nm emission filters were used to monitor the generation of ROS in neurons treated with 10 μM Aβ(25-35) for 36 h (24, 25).
Examination of learning and memory
Passive avoidance task: On day 1, A. cordata, donepezil (generously provided by Eisai Co., Ltd., Tokyo), and verapamil were administered to 5-week-old ICR mice and 30 min later, the aggregated form of Aβ (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) was administered i.c.v. using a microsyringe with a 27-gauge stainless-steel needle (Hamilton, Reno, NV, USA), the tip of which had been adjusted to a depth of 3 mm. The needle was inserted unilaterally 2 mm to the right of the midline point equidistant from each eye, at an equal distance between the eyes and the ears, and perpendicular to the plane of the skull (26) . The injection volume of Aβ(25-35) was 15 μl (15 nmol). A. cordata (50 and 100 mg/kg, p.o.) suspended in distilled water, donepezil (2 mg/kg, p.o.), and verapamil (20 mg/kg, p.o.) were administered daily for 7 days. At 30 min after administration of A. cordata, donepezil and verapamil on day 7, mice were trained on a one-trail step-through passive avoidance task. The passive avoidance box was divided into two chambers separated by a guillotine door and equipped with a grid floor and a shock generator (Gemini Avoidance System, San Diego, CA, USA). During the acquisition trial, each mouse was placed into the start chamber and kept in the dark until it was illuminated. After 50 s, the start chamber was illuminated and the door was opened for the mouse to move into the dark chamber freely. Immediately after the mouse entered the dark chamber, the door was closed and the mouse received an inescapable electric shock (0.3 mA, 2 s). In the retention trial given 24 h after the acquisition trial, the mouse was again placed in the chamber and illuminated 50 s later, and the time it took until it re-entered the dark chamber was measured (the step-through latency, maximum testing limit was 300 s). To test for any possible effect of Aβ(25-35) on motor function, the locomotor activity of the animals was measured using a photobeam monitoring system (AM1051; Benwick Electronics, Benwick, UK), and motor coordination was measured using a rota-rod apparatus (Daejong Inc., Seoul, Korea). Each mouse was placed in the center of the activity cage and the total number of beam interruptions was registered for 5 min. Then the mouse was put on the rota-rod for 2 min and the number of falls from the rod was noted.
Brain cholinesterase activity measurement: After the retention trial of the passive avoidance test, the mice were anesthetized deeply with diethyl ether and their brains were removed. Whole brain homogenates of cholinesterase preparation were prepared in a 50-fold volume of 10 mM phosphate buffer on ice. The concentration of acetylcholine (ACh) added as substrate of and hydrolyzed by cholinesterase was determined by the method of Hestrin (27) with a slight modification to measure brain cholinesterase activity. Briefly, aliquots (0.5 ml) of brain homogenates were mixed with 1 mL of 8 mM ACh, 0.4 ml of 0.1 mM phosphate buffer, and 0.1 ml distilled water. After adequate blending, the mixtures were incubated at 37°C for 30 min. The reaction was stopped by the addition of 2 ml alkalized hydroxylamine, and 0.5 ml of 4 N HCl and 0.5 ml of 0.37 M FeCl 3 were added to the reaction mixture. Absorbance was read at 540 nm and calibrated with a blank and an ACh standard.
Histological examination: After the retention trial of the passive avoidance test, five mice in each group were anesthetized deeply with diethyl ether, and then the brains were perfused transcardially with cold heparinized phosphate-buffered saline (PBS, pH 7.2), removed, and fixed in 10% (v/v) formalin solution in PBS for 72 h. The brains were then embedded in paraffin and representative coronal sections (5-μm-thick) that included the dorsal hippocampus were obtained using a rotary microtome (HM 315; Microm GmbH, Walldorf, Germany). The tissue sections were stained with hematoxylin and eosin (H&E). The sections were dehydrated, mounted in Canada balsam, and then analyzed using a brightfield microscope (CX21; Olympus, Tokyo). The number of pyramidal cells in the CA1 region of the hippocampus was counted.
Statistical analyses
Data are expressed as the mean ± S.E.M. and statistical significance was assessed by one-way analysis of variance (ANOVA) and Tukey's tests. P<0.05 was considered significant.
Results
A. cordata and oleanolic acid inhibit Aβ(25-35)-induced neuronal cell death
The concentration of 10 μM was used for determining Aβ(25-35)-induced neuronal cell damage in the present experiments based on our previous results (28) . When cortical neurons were exposed to 10 μM Aβ(25-35) for 36 h, absorbance in the MTT assay was 67.8 ± 1.3% of the control level (untreated cells) (Fig. 2) , indicating that Aβ(25-35) caused neuronal cell death. In cultures treated with A. cordata (1, 5, or 10 μg/ml), the Aβ(25-35)-induced neuronal death was significantly reduced (absorbance: 84.4 ± 1.7% of the control with 10 μg/ml A. cordata). To determine which components of A. cordata exhibit neuroprotective activity, we examined several compounds including diterpenes, triterpenes such as oleanolic acid, and saponins isolated from A. cordata (data not shown). Of these, only oleanolic acid protected against Aβ(25-35)-induced neurotoxicity in cultured cortical neurons. Pretreatment of cortical neurons with 1 and 5 μM oleanolic acid reduced the neuronal death induced by 10 μM Aβ(25-35) (absorbance: 76.2 ± 1.2% and 81.1 ± 1.4% of control, respectively; Fig. 2 ). MK-801 (10 μM), verapamil (5 μM), and L-NAME (1 mM) also inhibited the 10 μM Aβ(25-35)-induced neuronal death (absorbance: 83.2 ± 3.9%, 88.3 ± 4.0%, and 88.7 ± 3.0% of the control, respectively; Fig. 2 ).
Hoechst 33342 staining was used to detect condensed or fragmented DNA, which is indicative of Aβ(25-35)-induced neuronal apoptotic death. Treatment of neurons with 10 μM Aβ(25-35)-induced apoptosis in 32.4 ± 0.8% of cultured cortical neurons, compared with 11.1 ± 0.7% in control cultures. The addition of A. cordata (10 μg/ml) or oleanolic acid (5 μM) significantly decreased Aβ(25-35)-induced apoptotic cell death to 20.1 ± 2.0% and 18.7 ± 2.0% of all neurons, respectively (Fig. 3) . Apoptotic cell death induced by 10 μM Aβ(25-35) was also blocked by pretreatment with MK-801 (10 μM), verapamil (5 μM), and L-NAME (1 mM) to 10.3 ± 1.4%, 14.5 ± 1.4%, and 16.0 ± 2.0%, respectively (Fig. 3) .
A. cordata and oleanolic acid inhibit Aβ (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) ] i rapidly increased in response to treatment with 10 μM Aβ (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) and then showed a slow and gradual decrease over 10 min (Fig. 4) . In contrast, pretreatment with A. cordata (10 μg/ml), oleanolic acid (5 μM), MK-801 (10 μM), verapamil (5 μM), and L-NAME (1 mM) significantly inhibited the increase of [Ca 
A. cordata and oleanolic acid inhibit Aβ(25-35)-induced ROS generation
To clarify the involvement of oxidative stress in Aβ neurotoxicity, we measured the accumulation of ROS after the exposure of the cells to Aβ(25-35) for 36 h. In H 2 DCF-DA-loaded cerebral cortical neurons, 10 μM Aβ(25-35) increased the fluorescence intensity, indicating that ROS were generated. In neurons treated with 10 μM Aβ (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) , the relative fluorescence increased approximately 2.5-fold to 108.8 ± 7.0 compared with the value in control neurons (43.3 ± 2.7; Fig. 6 ). The Aβ(25-35)-induced increase in ROS generation was significantly inhibited by A. cordata (5 and 10 μg/ml) and oleanolic acid (0.5, 1, and 5 μM). MK-801 (10 μM), verapamil (5 μM), and L-NAME (1 mM) also significantly blocked the Aβ(25-35)-induced increase of ROS generation (Fig. 6) .
A. cordata inhibits Aβ(25-35)-induced memory impairment and neuronal death in mice
In the initial acquisition trial of the passive avoidance task, the step-through latency did not differ among the (Fig. 7) . Chronic administration of donepezil (2 mg/kg), a cholinesterase inhibitor, and verapamil (20 mg/kg) also protected against Aβ(25-35)-induced memory impairment (step-through latency: 143.3 ± 31.2 and 199.6 ± 31.3, respectively; Fig. 7 ). MK-801 (0.1 mg /kg, i.p.) and L-NAME (50 mg/kg, s.c.), however, failed to inhibit Aβ(25-35)-induced memory impairment (data not shown). To elucidate whether A. cordata affects general motor functions, we measured spontaneous locomotor activity and motor coordination in the mice. Neither A. Cordata nor Aβ (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) significantly affected locomotor and rota-rod activity (data not shown), indicating that the observed improvement of memory by A. cordata was not due to immobility.
Exposure to 15 nmol Aβ(25-35) produced a signifi- cant increase in cholinesterase activity in the brain. In the group consuming 100 mg/ kg A. cordata, the cholinesterase activity was significantly decreased compared with the Aβ(25-35) group (Table 1) .
We examined the subsequent histological changes in the hippocampus of Aβ (25-35) 
Discussion
As an active partial fragment of Aβ, Aβ(25-35) forms a β-sheet structure and induces neuronal cell death, neuritic atrophy, synaptic loss, and memory impairment, although it is not found in the AD brain (15, 26, 29, 30 ). The present study demonstrated that Aβ (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) 
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] i increase, glutamate release, ROS generation, and neuronal cell death in cultured cortical neurons, all of which were blocked by treatment with MK-801, an NMDA antagonist; verapamil, an L-type Ca 2+ channel blocker; and L-NAME, a NOS inhibitor. These results supporting the involvement of NMDA glutamatereceptor activation, increased Ca 2+ influx, and generation of ROS in Aβ(25-35)-induced neurotoxicity in cultured neurons are consistent with the results of other studies (3, 31 -33) . Regardless of the relative contribution of these events to Aβ(25-35)-induced neurotoxicity, the primary event following Aβ(25-35) treatment of cultured neurons has been suggested to be Ca 2+ influx, (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) were observed using a brightfield microscope. Panels a and f represent the control group; panels b and g, Aβ-injected group; panels c and h, Aβ + 100 mg /kg AC group; panels d and i, Aβ + 2 mg/kg donepezil group; panels e and j, Aβ + 20 mg/ kg verapamil group. Panels a -e represent the hippocampus (×40); panels f -j, CA 1 region (×400). Values are expressed as the mean ± S.E.M of cell numbers from five mice. ## P<0.01 vs. control; *P<0.05, **P<0.01 vs. Aβ (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) ] i increase, glutamate release, ROS generation, and neuronal cell death in cultured cortical neurons in the current study. This result indicates that A. cordata might prevent Ca 2+ entry through VDCC-and/or NMDAreceptor-coupled channels to inhibit Aβ(25-35)-induced neuronal death, although the mechanism by which A. cordata blocks the channels is not clear. A. cordata has been reported to possess antioxidant principles such as those of diterpenes and triterpenes (35, 36) , suggesting that inhibition of Aβ(25-35)-induced neuronal death by A. cordata might be due to their ROS-scavenging activity. Furthermore, diterpenes and triterpenes have been demonstrated to inhibit Ca 2+ entry through Ca 2+ channels (37, 38) , indicating that these compounds, including oleanolic acid, may contribute to the inhibitory activity of A. cordata on Ca 2+ entry through VDCC-and/or NMDA-receptor-coupled channels to inhibit Aβ(25-35)-induced neuronal death. Further study to elucidate the precise mechanism should be performed.
Many researchers have demonstrated that Aβ triggers apoptotic degeneration in in vitro neuronal experiments (3, 39) . In the present work, cultured cortical neurons exposed to Aβ (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) for 36 h showed increased chromatin condensation, a typical feature of apoptotic cell death, which was reduced by A. cordata. Aβ-induced apoptosis was also associated with COX-2 upregulation, and COX has been suggested to be an important source of ROS in the pathologic brain (40, 41) . Therefore, the protective effect of A. cordata against the Aβ-induced neurotoxicity might result from the inhibition of COX-1 and COX-2 (20, 21) . A. cordata inhibits chondrocyte apoptosis through the downregulation of JNK and p38 MAP kinase signaling and the inhibition of caspase-3 activity (42) . A. cordata could therefore prevent any step of the apoptotic cascade. The molecular mechanism for the prevention of neuronal apoptosis by A. cordata should be further clarified.
I.c.v. injection of Aβ (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) into experimental rodents induces memory impairment in different behavioral paradigms, including spontaneous alternation, the water maze, and passive avoidance (26, 43) . Aβ (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) preferentially impairs spatial and non-spatial short-term memory, and these effects remain evident up to 6 months after even a single i.c.v. injection of the peptide (44) . Memory impairment in the passive avoidance test was also confirmed in mice 7 days after the i.c.v. injection of Aβ (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (45, 46) , and A. cordata protected against this. These results were consistent with its protective effect against Aβ(25-35)-induced neurotoxicity in vitro. Aβ accumulation associated with cognitive impairment in AD is accompanied by an increase in cholinesterase activity (47) ; consistent with this, the increase of cholinesterase activity by Aβ (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) in the brain was inhibited by A. cordata in the present study. The present study also demonstrated the protection by donepezil, a cholinesterase inhibitor, against Aβ(25-35)-induced memory impairment. In addition, A. cordata administration significantly prevented scopolamine-induced learning and memory impairment, reducing escape latency during training in the Morris water maze test, a spatial task that is sensitive to impaired cholinergic function in the hippocampus (48) (data not shown). Taken together, these results suggest that A. cordata increases cholinergic activity.
On the other hand, other studies have indicated that oxidative stress is responsible for the onset of the cognitive dysfunction as well as the progression of AD (31, 49) . Elevated levels of Aβ induce oxidative stress, increasing the appearance of ROS such as superoxide (O 2 − ) and NO and subsequently producing ONOO − by a rapid interaction, could mediate the damage seen in AD (49, 50) . A scavenger of ONOO − protects against Aβ(25-35)-induced memory impairment (51) , and antioxidants such as α-tocopherol protect against cytotoxicity in vitro as well as against learning and memory deficits induced by Aβ (12) . In the present study, 10 μM Aβ (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) significantly increased the ROS level in cultured neurons, and this was inhibited by A. cordata. In addition, Aralia species contain antioxidant components (35, 36) . Therefore, it is possible that the favorable effect of A. cordata on Aβ(25-35)-induced cognitive deficits can be attributed to the inhibition of ROS generation. The attenuation of memory impairment by A. cordata is likely to be a corollary of its inhibition of Aβ (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) 
-induced [Ca
2+
] i , because memantine was demonstrated to have therapeutic benefits on AD due to its affinity for the NMDA-receptor Ca 2+ channel (52) . Moreover, the possible contribution of the blocking effect of donepezil, an acetylcholinesterase inhibitor, on the voltage-gated Ca 2+ channels to the neuroprotective effect in AD was reported (53) . In support of this hypothesis, verapamil, an L-type Ca 2+ channel blocker, inhibited Aβ(25-35)-induced memory impairment in the present study. Quartermain and Garcia deSoria also reported enhancing effects of Ca 2+ -channel antagonists on passive avoidance and maze learning (54, 55) , although there are controversial reports about the mnemonic effect of Ca
-channel antagonists (56, 57) . However, we failed to demonstrate the inhibitory effects of MK-801 and L-NAME on Aβ(25-35)-induced memory deficits. These results are consistent with the reports showing the impairment of learning and memory by NMDA-receptor antagonists and the role of NO on learning and memory in animals (58 -61) .
Oleanolic acid isolated from the aerial part of A. cordata also protected against Aβ(25-35)-induced neuronal damage. Oleanolic acid was able to reduce the Aβ-induced [Ca
] i increase, glutamate release, and ROS generation and, as a result, to attenuate neuronal apoptotic death in primary cultures of rat cortical neurons. Therefore, the inhibition by A. cordata of the Aβ(25-35)-induced memory deficit as well as neuronal damage in cultures may be attributable, at least in part, to the beneficial effects of oleanolic acid. Oleanolic acid is found naturally in various medicinal herbs traditionally used for anti-inflammatory, analgesic, hepatoprotective, and cardiotonic effects (62) and in rats has been reported to protect against myocardial ischemia-reperfusion injury by enhancing antioxidant activity of the mitochondria mediated by glutathione and α-tocopherol (63) . Oleanolic acid has also been reported to have inhibitory activity against COX-1 and COX-2 (21). Although there has been no evidence up until now to show that oleanolic acid antagonizes Aβ(25-35)-induced neurotoxicity, the present study demonstrated a novel pharmacological activity of oleanolic acid in neurons.
In conclusion, the protection against Aβ(25-35)-induced neuronal cell damage in culture and Aβ(25-35)-induced memory deficit in vivo may explain the inhibitory action of A. cordata on the progression of AD. Further studies should determine the specific components in A. cordata that are responsible for preventing the cognitive deficits.
